| Literature DB >> 33157998 |
Lina Zhao1, Lijiao Zhao2, Yun Ying Wang1, Fei Yang1, Zhuang Chen1, Qing Yu1, Hui Shi1, Shiying Huang1, Xiaoli Zhao1, Limei Xiu1, Xiaolu Li1, Yun Li3.
Abstract
During sepsis, platelets dysfunction contributes to organ dysfunction. Studies on platelets dysfunction in the long-term prognosis of sepsis are lacking. The aim of this study was to assess the role of platelets in the long-term prognosis of sepsis patients.A total of 4576 sepsis patients were extracted from MIMIC III Database. Survival was analyzed by the Kaplan-Meier method. Univariate and multivariate cox analyses were performed to identify prognostic factors. Significant prognostic factors were combined to build a nomogram to predict 1 year overall survival (OS). The discriminative ability and predictive accuracy of the nomogram were evaluated using the receiver operating characteristic curve (ROC) analysis and calibration curves used for sepsis.The more abnormal the platelet level, the worse prognosis of patients. After final regression analysis, age, blood urea nitrogen, platelets, international normalized ratio, partial thromboplastin time, potassium, hemoglobin, white blood cell count, organ failures were found to be independent predictors of 1 year OS of sepsis patient and were entered into a nomogram. The nomogram showed a robust discrimination, with an area under the receiver operating characteristic curve of 0.752. The calibration curves for the probability of the prognosis of sepsis patients showed optimal agreement between the probability as predicted by the nomogram and the actual probability.Platelet was an independent prognostic predictor of 1 year OS for patients with sepsis. Platelet-related nomogram that can predict the 1 year OS of sepsis patients. It revealed optimal discrimination and calibration, indicating that the nomogram may have clinical utility.Entities:
Mesh:
Year: 2020 PMID: 33157998 PMCID: PMC7647525 DOI: 10.1097/MD.0000000000023151
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1A flow chart of research methodology.
Figure 2Flow chart of patient selection. MIMIC-III, Medical Information Mart for Intensive Care I.
Baseline characteristics, vitalsigns, laboratory parameters and outcomes of patients.
| Thrombocytosis group | Normal platelets group | Thrombocytopenia group | ||
| n = 773 | n = 2686 | n = 1117 | ||
| Baseline variables | ||||
| Age | 56.9 (68.7–78.1) | 56.4 (68.2–79.0) | 50.7 (61.6–73.3) | <.001 |
| Sex (%) | ||||
| Female | 347 (44.9) | 1102 (41.0) | 466 (41.7) | .158 |
| Male | 426 (55.1) | 1584 (59.0) | 651 (58.3) | |
| Ethnicity (%) | ||||
| White | 563 (72.8) | 1914 (71.2) | 777 (69.6) | .265 |
| Black | 62 (8.0) | 255 (9.5) | 91 (8.1) | |
| Asian | 16 (2.1) | 64 (2.4) | 33 (3.0) | |
| Others | 132 (17.1) | 453 (16.9) | 216 (19.3) | |
| Admission type (%) | ||||
| Emergency | 715 (92.5) | 2468 (91.9) | 1018 (91.1) | .350 |
| Elective | 23 (3.0) | 68 (2.5) | 40 (3.6) | |
| Urgent | 35 (4.5) | 150 (5.6) | 59 (5.3) | |
| Vital signs | ||||
| HR | 79.6 (90.5–102.7) | 78.6 (89.6–102.6) | 82 (94.3–106.5) | <.001 |
| SBP | 101.4 (110–121.1) | 101.6 (109.6–121.0) | 99.6 (107.6–118.2) | <.001 |
| DBP | 50.8 (56.8–63.4) | 51.8 (57.2–64.0) | 51.6 (57.9–64.4) | .112 |
| MBP | 66.6 (72.2–79.8) | 67.3 (73.0–80.0) | 67.0 (72.8–80.0) | .367 |
| RR | 17.6 (20.7–24.1) | 17.5 (20.1–23.5) | 17.4 (20.8–24.7) | .003 |
| T | 36.4 (36.9–37.4) | 36.4 (36.9–37.4) | 36.3 (36.8–37.3) | <.001 |
| Laboratory parameters | ||||
| Cr (mg/dl) | 0.8 (1.3–2.3) | 1.0 (1.4–2.5) | 1.0 (1.5–2.7) | <.001 |
| Glu (mg/dl) | 91 (108–135) | 89 (108–132) | 84 (104–127) | <.001 |
| Hemoglobin (g/dl) | 8.4 (9.5–10.7) | 8.8 (10.0–11.3) | 7.8 (8.9–10.2) | <.001 |
| Platelets (×109 /L) | 336 (376–451.5) | 138 (177–224.2) | 37 (59–78) | <.001 |
| PTT (s) | 28.6 (33.9–47.7) | 29.8 (36.4–47.7) | 33.6 (42.1–59.6) | <.001 |
| INR | 1.2 (1.4–2.0) | 1.2 (1.5–2.0) | 1.4 (1.8–2.4) | <.001 |
| PT (s) | 13.8 (15.4–19.0) | 14.0 (15.8–19.0) | 15.1 (17.7–22.6) | <.001 |
| BUN (mg/dl) | 18 (28–49) | 19 (30–49.2) | 21 (34–55) | <.001 |
| WBC (×109 /L) | 13.4 (18.2–25.25) | 10.1 (14.6–20.5) | 5.5 (10.5–17.4) | <.001 |
| Potassium_min (mmol/L) | 3.5 (3.9–4.4) | 3.4 (3.8–4.2) | 3.3 (3.7–4.1) | .794 |
| Potassium_max (mmol/L) | 4.1 (4.5–5.0) | 4.0 (4.4–5.0) | 3.9 (4.4–4.9) | <.001 |
| Sodium_min (mmol/L) | 133 (137–140) | 134 (137–140) | 133 (137–140) | .001 |
| Sodium_max (mmol/L) | 136 (139–142) | 137 (140–143) | 136 (140–143) | <.001 |
| Score system | ||||
| SAPSII | 32 (42–53) | 32 (42–53) | 37 (47–59) | <.001 |
| SOFA | 3.0 (5.0–7.0) | 4.0 (6.0–8.0) | 6 (9.0–12.0) | <.001 |
| GCS | 14 (15–15) | 13 (15–15) | 14 (15–15) | .008 |
| Outcome (%) | ||||
| Mechanical ventilation, n (%) | 444 (57.4) | 1471 (54.8) | 691 (61.9) | .135 |
| Renal replacement therapy, n (%) | 32 (4.1) | 169 (6.3) | 159 (14.2) | <.001 |
| Vasopressors, n (%) | ||||
| Norepinephrine | 319 (41.3) | 1158 (43.1) | 566 (50.7) | <.001 |
| Dopamine | 98 (12.7) | 365 (13.6) | 154 (13.8) | .762 |
| Epinephrine | 19 (2.5) | 97 (3.6) | 52 (4.7) | .066 |
| Organ failure, n (%) | ||||
| Renal | 436 (56.4) | 1600 (59.6) | 743 (66.5) | <.001 |
| Hepatic | 35 (4.5) | 235 (8.7) | 254 (22.7) | .001 |
| Cardiovascular | 308 (39.8) | 1126 (41.9) | 551 (49.3) | <.001 |
| Respiratory | 430 (55.6) | 1461 (54.4) | 699 (62.6) | <.001 |
| Hematologic | 53 (6.9) | 465 (17.3) | 585 (52.4) | <.001 |
| 1 OS | 397 (51.4) | 1178 (43.9) | 698 (62.5) | <.001 |
| Hospital mortality | 219 (28.3) | 699 (26.0) | 502 (44.9) | <.001 |
Figure 3Kaplan–Meier survival curves for patients with normal and abnormal platelet indices were compared and log-rank test were assessed for significance.
Univariate and multivariate analysis of risk factors to 1year OS.
| Univariate analysis | Multivariate analysis | |||||||
| 95.0% CI | 95.0% CI | |||||||
| OR | Lower | Upper | OR | Lower | Upper | |||
| Age | <.001 | 1.021 | 1.018 | 1.024 | <.001 | 1.024 | 1.020 | 1.027 |
| Sex | .599 | 1.023 | 0.941 | 1.111 | ||||
| Cr(mg/dl) | <.001 | 1.072 | 1.054 | 1.090 | .847 | 0.997 | 0.970 | 1.026 |
| BUN(mg/dl) | <.001 | 1.010 | 1.009 | 1.011 | <.001 | 1.004 | 1.003 | 1.006 |
| Glu(mg/dl) | .009 | 1.000 | 1.000 | 1.001 | .415 | 1.000 | 0.999 | 1.001 |
| Hemoglobin(g/dl) | <.001 | 0.910 | 0.890 | 0.930 | <.001 | 0.947 | 0.925 | 0.968 |
| Platelet(X109 /L) | ||||||||
| 100–300(reference) | 1.000 | 1.000 | ||||||
| <100 | <.001 | 1.730 | 1.575 | 1.900 | <.001 | 1.684 | 1.517 | 1.871 |
| >300 | .001 | 1.211 | 1.081 | 1.357 | .022 | 1.145 | 1.019 | 1.286 |
| INR | <.001 | 1.097 | 1.083 | 1.112 | <.001 | 1.067 | 1.045 | 1.089 |
| PTT(s) | <.001 | 1.007 | 1.006 | 1.009 | <.001 | 1.004 | 1.003 | 1.005 |
| PT(s) | <.001 | 1.015 | 1.012 | 1.019 | .382 | 0.998 | 0.994 | 1.002 |
| WBC(X 109 /L) | <.001 | 1.002 | 1.001 | 1.003 | .027 | 1.002 | 1.000 | 1.003 |
| Sodium_min(mmol/L) | .097 | 0.994 | 0.986 | 1.001 | ||||
| Sodium_max(mmol/L) | .679 | 0.998 | 0.991 | 1.006 | ||||
| Potassium_min(mmol/L) | <.001 | 1.396 | 1.341 | 1.484 | <.001 | 1.217 | 1.133 | 1.309 |
| Potassium_max(mmol/L) | <.001 | 1.186 | 1.150 | 1.222 | .146 | 1.039 | 0.978 | 1.095 |
| Organ failure,n(%) | ||||||||
| Renal | <.001 | 1.746 | 1.596 | 1.909 | .016 | 1.135 | 1.024 | 1.258 |
| Hepatic | <.001 | 3.443 | 2.859 | 4.418 | <.001 | 1.455 | 1.285 | 1.648 |
| Cardiovascular | <.001 | 1.617 | 1.489 | 1.756 | <.001 | 1.251 | 1.148 | 1.363 |
| Respiratory | <.001 | 1.927 | 1.766 | 2.103 | <.001 | 1.794 | 1.639 | 1.936 |
| Hematologic | <.001 | 1.312 | 1.196 | 1.439 | .159 | 0.928 | 0.836 | 1.030 |
Figure 4Nomograms for the prediction of the 1 year OS in patients with sepsis. To use the nomogram, first, the position of each variable on the corresponding axis should be found. Next, a line to the points axis for the number of points should be drawn. Then, the points from all the variables should be added. Finally, a line from the total points axis should be drawn to determine the overall survival probabilities at the lower line of the nomogram. The total points projected to the bottom scale indicate the % probability of the 1-year survival. BUN = blood urea nitrogen, INR = international normalized ratio, OS = overall survival, PTT = partial thromboplastin time.
Figure 5The calibration curves for the predictions of 1 year OS and the validation, The dashed line represents perfect correspondence between the probabilities predicted by the nomogram (x-axis) and calculated by Kaplan-Meier analysis (y-axis), respectively. OS = overall survival.
Figure 6Discriminatory accuracy for predicting OS assessed by receiver operator characteristics (ROC) analysis calculating area under the curve (AUC).